128 related articles for article (PubMed ID: 36585185)
21. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
[TBL] [Abstract][Full Text] [Related]
22. UVB radiation induces expression of HIF-1alpha and VEGF through the EGFR/PI3K/DEC1 pathway.
Li Y; Bi Z; Yan B; Wan Y
Int J Mol Med; 2006 Oct; 18(4):713-9. PubMed ID: 16964427
[TBL] [Abstract][Full Text] [Related]
23. MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition.
Dai M; Miao ZH; Ren X; Tong LJ; Yang N; Li T; Lin LP; Shen YM; Ding J
J Cell Mol Med; 2010 Sep; 14(9):2281-91. PubMed ID: 19538463
[TBL] [Abstract][Full Text] [Related]
24. Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells.
Zhou J; Zhang S; Xue J; Avery J; Wu J; Lind SE; Ding WQ
J Biol Chem; 2012 Oct; 287(42):35161-35169. PubMed ID: 22932900
[TBL] [Abstract][Full Text] [Related]
25. EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation.
Lee JH; Liu R; Li J; Wang Y; Tan L; Li XJ; Qian X; Zhang C; Xia Y; Xu D; Guo W; Ding Z; Du L; Zheng Y; Chen Q; Lorenzi PL; Mills GB; Jiang T; Lu Z
Mol Cell; 2018 Apr; 70(2):197-210.e7. PubMed ID: 29677490
[TBL] [Abstract][Full Text] [Related]
26. Activation of HIF-1
Schoos A; Gabriel C; Knab VM; Fux DA
J Pharmacol Exp Ther; 2019 Sep; 370(3):480-489. PubMed ID: 31300611
[TBL] [Abstract][Full Text] [Related]
27. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.
Cascio S; D'Andrea A; Ferla R; Surmacz E; Gulotta E; Amodeo V; Bazan V; Gebbia N; Russo A
J Cell Physiol; 2010 Jul; 224(1):242-9. PubMed ID: 20232316
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.
Kallergi G; Markomanolaki H; Giannoukaraki V; Papadaki MA; Strati A; Lianidou ES; Georgoulias V; Mavroudis D; Agelaki S
Breast Cancer Res; 2009; 11(6):R84. PubMed ID: 19919679
[TBL] [Abstract][Full Text] [Related]
29. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway.
Park JH; Lee JY; Shin DH; Jang KS; Kim HJ; Kong G
Oncogene; 2011 Nov; 30(45):4578-89. PubMed ID: 21602890
[TBL] [Abstract][Full Text] [Related]
30. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
31. [Clinical research on the expression of three vascular regulatory factors in different morphological regions of Marjolin ulcer and their relationship with angiogenesis].
Xia C; Chu ZG
Zhonghua Shao Shang Za Zhi; 2019 Sep; 35(9):676-682. PubMed ID: 31594186
[No Abstract] [Full Text] [Related]
32. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin.
Dal Monte M; Martini D; Ristori C; Azara D; Armani C; Balbarini A; Bagnoli P
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):593-612. PubMed ID: 21523559
[TBL] [Abstract][Full Text] [Related]
34. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha.
Kim HJ; Chung H; Yoo YG; Kim H; Lee JY; Lee MO; Kong G
Mol Cancer Res; 2007 Apr; 5(4):321-9. PubMed ID: 17426247
[TBL] [Abstract][Full Text] [Related]
35. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of ERRα inhibits angiogenesis in human umbilical vein endothelial cells through regulating VEGF production and PI3K/Akt/STAT3 signaling pathway.
Zhang LD; Chen L; Zhang M; Qi HJ; Chen L; Chen HF; Zhong MK; Shi XJ; Li QY
Eur J Pharmacol; 2015 Dec; 769():167-76. PubMed ID: 26586335
[TBL] [Abstract][Full Text] [Related]
37. PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer.
Yeerken D; Hong R; Wang Y; Gong Y; Liu R; Yang D; Li J; Fan J; Chen J; Zhang W; Zhan Q
PLoS One; 2020; 15(5):e0233750. PubMed ID: 32470015
[TBL] [Abstract][Full Text] [Related]
38. HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions.
Fanale D; Bazan V; Corsini LR; Caruso S; Insalaco L; Castiglia M; Cicero G; Bronte G; Russo A
Breast Cancer Res Treat; 2013 Aug; 140(3):505-17. PubMed ID: 23925655
[TBL] [Abstract][Full Text] [Related]
39. [Effect and mechanism of apigenin on VEGF expression in human breast cancer cells].
Jin XY; Ren CS
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):495-9. PubMed ID: 18069627
[TBL] [Abstract][Full Text] [Related]
40. DEPTOR Deficiency-Mediated mTORc1 Hyperactivation in Vascular Endothelial Cells Promotes Angiogenesis.
Ding Y; Shan L; Nai W; Lin X; Zhou L; Dong X; Wu H; Xiao M; Zhou X; Wang L; Li T; Fu Y; Lin Y; Jia C; Dai M; Bai X
Cell Physiol Biochem; 2018; 46(2):520-531. PubMed ID: 29614494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
